Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 13, 2018

SELL
$17.4 - $23.4 $5.48 Million - $7.36 Million
-314,680 Closed
0 $0
Q3 2017

Nov 14, 2017

SELL
$15.5 - $19.15 $975,508 - $1.21 Million
-62,936 Reduced 16.67%
314,680 $5.6 Million
Q2 2017

Aug 14, 2017

BUY
N/A
377,616
377,616 $6.67 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $7.55B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Partners Group Holding Ag Portfolio

Follow Partners Group Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Partners Group Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Partners Group Holding Ag with notifications on news.